Condition: Chronic Lymphocytic Leukemia · Lymphoma, Small Lymphocytic · Sponsor: Eli Lilly and Company
This study will evaluate the long-term safety of pirtobrutinib in participants with previously treated chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL). The study is open to those who completed J2N-MC-JZNN/LOXO-BTK-20020 (NCT 04666038) for continued access to the study intervention or continued follow-up visits. Treatment will be given every 4 weeks and this study is expected to last about 5 years.
This description comes directly from the study's public registry record.
Trial questions or participation questions: 1-877-CTLILLY (1-877-285-4559) or · 1-317-615-4559 · LillyTrials@Lilly.com
Physicians interested in becoming principal investigators please contact · clinical_inquiry_hub@lilly.com
Always discuss trial participation with your own doctor first.
| Mitchell Cancer Institute | Mobile, Alabama, United States | Recruiting |
| Arizona Oncology Associates, P.C. - HOPE | Tucson, Arizona, United States | Not Yet Recruiting |
| Cancer Specialists, LLC | Jacksonville, Florida, United States | Recruiting |
| Minnesota Oncology Hematology, P.A. | Coon Rapids, Minnesota, United States | Not Yet Recruiting |
| Cayuga Cancer Center | Ithaca, New York, United States | Not Yet Recruiting |
| Memorial Sloan-Kettering Cancer Center (MSKCC) - New York | New York, New York, United States | Recruiting |
| Oncology Hematology Care Inc | Cincinnati, Ohio, United States | Not Yet Recruiting |
| Texas Oncology - Paris | Fort Worth, Texas, United States | Not Yet Recruiting |
| US Oncology - Texas Oncology | Kyle, Texas, United States | Not Yet Recruiting |
| The Alfred Hospital | Melbourne, Australia | Not Yet Recruiting |
| LKH - Universitätsklinikum der PMU Salzburg | Salzburg, Austria | Not Yet Recruiting |
| AZ Delta | Roeselare, Belgium | Not Yet Recruiting |
+ 38 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07218341